CELG

7 Major Pharmaceutical Stocks to Quarantine Now

By Josh Enomoto, InvestorPlace Contributor Dec 17, 2018

Despite their indispensable demand, pharmaceutical stocks face tough roadblocks as competition for breakthrough drugs intensifies.

5 Pharma Stocks That Could Cure Ailing Portfolios in 2019

By Will Healy, InvestorPlace Contributor Dec 12, 2018

These pharma stocks offer low multiples and growth catalysts that could offer relief to investors in the coming year.

5 Top Stock Trades for Tuesday: NFLX, AMD, SQ, QQQ

By Bret Kenwell, InvestorPlace Contributor Dec 3, 2018

Netflix gave up all of its big gains, but AMD didn't. The QQQ, Celgene and Square could be hitting resistance in our top stock trades.

3 Beaten-Down Biotech Stocks to Buy Before the End of 2018

By Tezcan Gecgil, InvestorPlace Contributor Nov 30, 2018

Biotech stocks are likely to continue to be volatile in December, but that may create unique buying opportunities.

5 Top Stock Trades for Thursday: Alphabet and the Market’s Rally

By Bret Kenwell, InvestorPlace Contributor Nov 28, 2018

Small caps led us into this mess, now can lead us out? Perhaps they can, with the help of FANG. Here are our top stock trades for Thursday.

Biogen Stock Rebounds After Impressive Q3 Earnings

By Chris Lau, InvestorPlace Contributor Nov 5, 2018

Biogen stock reaffirmed its dominance in MS and the neurosciences market. At a low P/E mutliple, investors should look at BIIB again.

7 Rising Healthcare Stocks to Consider

By Chris Lau, InvestorPlace Contributor Oct 29, 2018

Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.

Gilead Sciences Stock Is Back to Base — Go Long

By Nicolas Chahine, InvestorPlace Contributor Oct 26, 2018

Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.

5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage

By Aaron Levitt, InvestorPlace Contributor Oct 17, 2018

After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.

10 Bargain-Bin Stocks to Buy

By James Brumley, InvestorPlace Feature Writer Oct 16, 2018

Celgene, Capital One and Lam Research are just some of the smartest stocks to buy after unmerited beat-downs.

7 Biotech Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor Sep 19, 2018

Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently.

3 Big Stock Charts for Thursday: Tiffany & Co., Celgene and Oneok

By James Brumley, InvestorPlace Feature Writer Aug 30, 2018

The stock charts of OKE, CELG and TIF have left behind some curious shapes and patterns that traders would be wise to scrutinize.

5 Healthcare Stocks That Are Down, But Not Out!

By Josh Enomoto, InvestorPlace Contributor Aug 29, 2018

Tough headwinds have impacted several healthcare stocks, presenting opportunities for risk-tolerant speculators.

Trade of the Day: Celgene Is Coiling Up for a Rally

By Serge Berger, InvestorPlace Contributor Aug 29, 2018

Biotechnology stocks have started to wake up, and Celgene looks primed to rally. CELG stock is at a key moving average, and a push above it could bring more buyers.